Li, H., Rong, Q., Huang, R., Chen, M., Zheng, Q., Xue, C., Su, Y., An, X., Shi, Y. (2026). Preliminary results of a randomized phase II trial of chidamide plus fulvestrant with or without sintilimab in HR+/HER2- advanced breast cancer after progression on CDK4/6 inhibitors (CISFORT).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.e13051